Logo image of CHCI

COMSTOCK HOLDING COMPANIES (CHCI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CHCI - US2056842022 - Common Stock

11.62 USD
+0.29 (+2.56%)
Last: 12/31/2025, 8:00:01 PM
11.62 USD
0 (0%)
After Hours: 12/31/2025, 8:00:01 PM
Fundamental Rating

7

Taking everything into account, CHCI scores 7 out of 10 in our fundamental rating. CHCI was compared to 63 industry peers in the Real Estate Management & Development industry. Both the health and profitability get an excellent rating, making CHCI a very profitable company, without any liquidiy or solvency issues. CHCI has a decent growth rate and is not valued too expensively. These ratings would make CHCI suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CHCI was profitable.
In the past year CHCI had a positive cash flow from operations.
In the past 5 years CHCI has always been profitable.
In the past 5 years CHCI always reported a positive cash flow from operatings.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

The Return On Assets of CHCI (20.57%) is better than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 24.71%, CHCI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.79%, CHCI belongs to the top of the industry, outperforming 98.41% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHCI is significantly above the industry average of 5.35%.
The 3 year average ROIC (18.89%) for CHCI is well above the current ROIC(12.79%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 20.57%
ROE 24.71%
ROIC 12.79%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

With an excellent Profit Margin value of 24.90%, CHCI belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
In the last couple of years the Profit Margin of CHCI has grown nicely.
CHCI has a better Operating Margin (16.59%) than 85.71% of its industry peers.
In the last couple of years the Operating Margin of CHCI has grown nicely.
CHCI's Gross Margin of 21.37% is in line compared to the rest of the industry. CHCI outperforms 47.62% of its industry peers.
CHCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.59%
PM (TTM) 24.9%
GM 21.37%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHCI is creating value.
CHCI has more shares outstanding than it did 1 year ago.
CHCI has more shares outstanding than it did 5 years ago.
CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 5.04 indicates that CHCI is not in any danger for bankruptcy at the moment.
CHCI's Altman-Z score of 5.04 is amongst the best of the industry. CHCI outperforms 82.54% of its industry peers.
CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.04
ROIC/WACC1.45
WACC8.82%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 3.95 indicates that CHCI has no problem at all paying its short term obligations.
CHCI has a Current ratio of 3.95. This is amongst the best in the industry. CHCI outperforms 85.71% of its industry peers.
CHCI has a Quick Ratio of 3.95. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CHCI (3.95) is better than 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 3.95
Quick Ratio 3.95
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 123.43% over the past year.
The Earnings Per Share has been growing by 61.08% on average over the past years. This is a very strong growth
CHCI shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.98%.
CHCI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.18% yearly.
EPS 1Y (TTM)123.43%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%-77.62%
Revenue 1Y (TTM)22.98%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%2.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.74, the valuation of CHCI can be described as very reasonable.
CHCI's Price/Earnings ratio is rather cheap when compared to the industry. CHCI is cheaper than 90.48% of the companies in the same industry.
CHCI is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.74
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHCI is valued cheaply inside the industry as 92.06% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CHCI is valued cheaper than 82.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.69
EV/EBITDA 9.51
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The excellent profitability rating of CHCI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CHCI!.
Industry RankSector Rank
Dividend Yield 0%

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (12/31/2025, 8:00:01 PM)

After market: 11.62 0 (0%)

11.62

+0.29 (+2.56%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-05 2025-11-05
Earnings (Next)03-19 2026-03-19
Inst Owners11.57%
Inst Owner Change31.91%
Ins Owners66.01%
Ins Owner Change-2.1%
Market Cap117.25M
Revenue(TTM)55.84M
Net Income(TTM)13.90M
Analysts0
Price TargetN/A
Short Float %0.98%
Short Ratio1.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.74
Fwd PE N/A
P/S 2.1
P/FCF 16.69
P/OCF 16.04
P/B 2.08
P/tB 2.09
EV/EBITDA 9.51
EPS(TTM)1.33
EY11.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY5.99%
OCF(TTM)0.72
OCFY6.23%
SpS5.53
BVpS5.58
TBVpS5.56
PEG (NY)N/A
PEG (5Y)0.14
Graham Number12.92
Profitability
Industry RankSector Rank
ROA 20.57%
ROE 24.71%
ROCE 16.19%
ROIC 12.79%
ROICexc 23.58%
ROICexgc 23.74%
OM 16.59%
PM (TTM) 24.9%
GM 21.37%
FCFM 12.58%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
ROICexc(3y)36.53%
ROICexc(5y)31.24%
ROICexgc(3y)36.83%
ROICexgc(5y)32.34%
ROCE(3y)23.91%
ROCE(5y)20.74%
ROICexgc growth 3Y10.99%
ROICexgc growth 5Y13.58%
ROICexc growth 3Y10.68%
ROICexc growth 5Y17.17%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
F-Score6
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 91.11%
Cap/Sales 0.51%
Interest Coverage 250
Cash Conversion 76.32%
Profit Quality 50.51%
Current Ratio 3.95
Quick Ratio 3.95
Altman-Z 5.04
F-Score6
WACC8.82%
ROIC/WACC1.45
Cap/Depr(3y)179.46%
Cap/Depr(5y)167.67%
Cap/Sales(3y)0.93%
Cap/Sales(5y)0.78%
Profit Quality(3y)87.69%
Profit Quality(5y)95.22%
High Growth Momentum
Growth
EPS 1Y (TTM)123.43%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%-77.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.98%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%2.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.59%
EBIT growth 3Y26.35%
EBIT growth 5Y34.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.03%
FCF growth 3Y10.69%
FCF growth 5Y4.68%
OCF growth 1Y17.9%
OCF growth 3Y11.03%
OCF growth 5Y4.91%

COMSTOCK HOLDING COMPANIES / CHCI FAQ

Can you provide the ChartMill fundamental rating for COMSTOCK HOLDING COMPANIES?

ChartMill assigns a fundamental rating of 7 / 10 to CHCI.


What is the valuation status of COMSTOCK HOLDING COMPANIES (CHCI) stock?

ChartMill assigns a valuation rating of 5 / 10 to COMSTOCK HOLDING COMPANIES (CHCI). This can be considered as Fairly Valued.


What is the profitability of CHCI stock?

COMSTOCK HOLDING COMPANIES (CHCI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of COMSTOCK HOLDING COMPANIES (CHCI) stock?

The Price/Earnings (PE) ratio for COMSTOCK HOLDING COMPANIES (CHCI) is 8.74 and the Price/Book (PB) ratio is 2.08.


How financially healthy is COMSTOCK HOLDING COMPANIES?

The financial health rating of COMSTOCK HOLDING COMPANIES (CHCI) is 9 / 10.